Annual Health Care Expenditure Higher for Hypertensive Patients

Share this content:
Annual Health Care Expenditure Higher for Hypertensive Patients
Annual Health Care Expenditure Higher for Hypertensive Patients

WEDNESDAY, May 30, 2018 (HealthDay News) -- Individuals with hypertension have a higher annual adjusted incremental expenditure of $1,920, according to a study published online May 30 in the Journal of the American Heart Association.

Elizabeth B. Kirkland, M.D., from the Medical University of South Carolina in Charleston, and colleagues used data from the Medical Expenditure Panel Survey to calculate the estimated annual health care expenditure for patients with hypertension and measure trends in expenditure longitudinally over a 12-year period. Adjusted incremental expenditures were estimated for individuals with and without hypertension. Pooled data from 2003 to 2014 were included for 224,920 adults, 36.9 percent of whom had hypertension.

The researchers found that the mean annual medical expenditure attributable to patients with hypertension was $9,089 in unadjusted analyses. Individuals with hypertension had a $1,920 higher annual adjusted incremental expenditure relative to individuals without hypertension, and they had 2.5 times the inpatient cost, almost double the outpatient cost, and almost triple the prescription medication expenditure. Based on the U.S. prevalence of hypertension, the estimated adjusted annual incremental cost was $131 billion per year higher for adults with versus those without hypertension.

"Individuals with hypertension are estimated to face nearly $2,000 higher annual health care expenditure compared with their non-hypertensive peers," the authors write. "This trend has been relatively stable over 12 years."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »